AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ciyasit M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Zuciya Lifesciences

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Ciyasit M 50mg/500mg Tablet

Diabex Duo 50mg/500mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lessening the risk of cardiovascular events. Diabex Duo may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, blood glucose readings, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes efficacy; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise plan is crucial for successful diabetes management, as lifestyle significantly impacts blood sugar control. Common side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; patients must be aware of its symptoms and management. This medication isn't universally suitable. Prior to use, inform your physician of any history of hepatic, renal, or cardiac disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should seek medical advice before commencing treatment. Interactions with other medications are possible; complete disclosure of all current medications is essential for safety. Alcohol should be limited due to its potential to reduce blood glucose. Kidney function and blood sugar levels will be monitored regularly throughout treatment.

Uses of Ciyasit M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Ciyasit M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ciyasit M 50mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Ciyasit M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Ciyasit M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ciyasit M 50mg/500mg Tablet whole; do not alter its form by chewing, crushing, or breaking. Administer this medicine with food.

How Ciyasit M 50mg/500mg Tablet works:

Ciyasit M, a 50mg/500mg tablet, combines sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action promotes superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Ciyasit M 50mg/500mg Tablet with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Ciyasit M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Ciyasit M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Ciyasit M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Ciyasit M 50mg/500mg tablets are contraindicated in those with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

The use of Ciyasit M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided unless otherwise directed by a physician.

What if you forget to take Ciyasit M 50mg/500mg Tablet :

Should you forget a Ciyasit M 50mg/500mg Tablet dose, take it immediately if you remember. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Ciyasit M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Ciyasit M 50mg/500mg Tablet

Ciyasit M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Ciyasit M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Ciyasit M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Ciyasit M 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Ciyasit M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Ciyasit M 50mg/500mg Tablets can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from high blood lactic acid levels. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Ciyasit M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Ciyasit M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Ciyasit M 50mg/500mg Tablet is contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Ciyasit M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Ciyasit M 50mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding the drug in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Ciyasit M 50mg/500mg Tablet can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Ciyasit M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Ciyasit M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Ciyasit M 50mg/500mg Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Ciyasit M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Ciyasit M 50mg/500mg Tablet. This rare complication is avoided in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Ciyasit M and seek immediate medical attention.
Prolonged use of Ciyasit M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Ciyasit M 50mg/500mg Tabl...
207